Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

NCT05219994 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT05219994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
Lead sponsor
University of Missouri-Columbia
Phase
Not applicable
Overall status
Completed
Start date
September 9, 2020
Completion date
May 10, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes